SCHEMBL949028

SCHEMBL949028

CCOC(=O)CC(O)Sc1ccc2cc(Cl)ccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.41
MEN1 O00255 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
TP53 P04637 1/20 0.40
THRB P10828 1/20 0.40
TDP1 Q9NUW8 3/20 0.39
ALDH1A1 P00352 4/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
PTGS2 P35354 1/20 0.38
CYP1A2 P05177 4/20 0.37
CYP3A4 P08684 4/20 0.37
CYP2C9 P11712 4/20 0.37
CYP2C19 P33261 4/20 0.37
TSHR P16473 3/20 0.37
HSD17B10 Q99714 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL950288 0.78 ALOX15 (0.43) ALOX15MEN1HPGDKMT2ATDP1
SCHEMBL948935 0.76 ALOX15 (0.43) ALOX15MEN1HPGDKMT2ATDP1
SCHEMBL949030 0.76 HTT (0.53) ALOX15MEN1HPGDKMT2AALDH1A1
SCHEMBL7014510 0.75 ALOX15 (0.42) ALOX15TDP1ALDH1A1LMNAMAPT
SCHEMBL7012021 0.74 MAPT (0.45) ALOX15MEN1HPGDKMT2ALMNA
SCHEMBL28562536 0.73 SMN1; SMN2 (0.51) MEN1HPGDKMT2ATDP1ALDH1A1
SCHEMBL16596060 0.70 CYP4F2 (0.56) ALOX15MEN1HPGDKMT2ATP53
SCHEMBL948236 0.69 CYP2C9 (0.45) CYP2C9CYP2C19TSHRHSD17B10
SCHEMBL947917 0.69 CYP2C9 (0.45) CYP2C9CYP2C19TSHRHSD17B10
SCHEMBL947915 0.69 MTNR1A (0.39) MEN1HPGDKMT2ALMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009389-A1 IMIDAZOLE DERIVATIVE, THEIR PRODUCTION AND USE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
US-20070004736-A1 Imidazole derivative, process for producing the same, and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-01-04 US disclosed
EP-1564213-A1 IMIDAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE Takeda Pharmaceutical Company Limited (JP) 2005-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004736-A1 Imidazole derivative, process for producing the same, and use HRH4, F2, HRH2 ALOX15 1326/4885MEN1 1291/4885HPGD 356/4885
US-20110009389-A1 IMIDAZOLE DERIVATIVE, THEIR PRODUCTION AND USE F2, H1-3, CYC1 ALOX15 1125/4885MEN1 1197/4885HPGD 248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.